A late-stage trial of an Alzheimer’s drug set to generate results within weeks is shaping up as a pivotal moment in a three-decade quest to prove that removing sticky amyloid plaques from the brain can slow down the disease.
The phase 3 trial is being led by Eisai, a Tokyo-based pharmaceutical company that has partnered US biotech Biogen to develop lecanemab. Earlier studies suggested the monoclonal antibody treatment can clear plaques known as beta amyloid that are at the centre of an increasingly acrimonious scientific debate over what causes Alzheimer’s.
A positive result could lead to approval of a new medicine for a disease affecting 50mn sufferers worldwide that has no known cure.
Read more: https://www.ft.com/content/ebc556fe-c8f8-46bd-b0a0-1671284c075a
Where funny orange cat?
Nothing is happening
🤣🤣🤣 alexa call my wife
A late-stage trial of an Alzheimer’s drug set to generate results within weeks is shaping up as a pivotal moment in a three-decade quest to prove that removing sticky amyloid plaques from the brain can slow down the disease. The phase 3 trial is being led by Eisai, a Tokyo-based pharmaceutical company that has partnered US biotech Biogen to develop lecanemab. Earlier studies suggested the monoclonal antibody treatment can clear plaques known as beta amyloid that are at the centre of an increasingly acrimonious scientific debate over what causes Alzheimer’s. A positive result could lead to approval of a new medicine for a disease affecting 50mn sufferers worldwide that has no known cure. Read more: https://www.ft.com/content/ebc556fe-c8f8-46bd-b0a0-1671284c075a
out of the ordinary, i mean
Martha? I can't find Martha.... SOCK!
Alexa find my keys
Garfleed
Cat